Newsfeeds Archive - Page 3 of 5

2 minute read

Why NeoGames Shares Are Trading Higher By 121%; Here Are 20 Stocks Moving Premarket

May 15, 8:03 AM

Gainers NeoGames S.A. (NASDAQ: NGMS) shares surged 121% to $28.38 in pre-market trading as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

ALGS

1 minute read

News

Aligos Therapeutics Announced Friday A Research Collaboration And Development Agreement With Xiamen Amoytop Biotech Co. Ltd. For Use Of Aligos’ Oligonucleotide Platform For Treatment Of Liver Diseases

By Charles Gross

May 15, 6:07 AM

Aligos Therapeutics, Inc. (NASDAQ:ALGS, ", Aligos", , the ", Company", )))), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and

ALGS

1 minute read

Earnings

Recap: Aligos Therapeutics Q1 Earnings

By Benzinga Insights

May 4, 5:45 PM

Aligos Therapeutics (NASDAQ:ALGS) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM. Here’s what…

ALGS

31 minute read

Earnings

Earnings Scheduled For May 4, 2023

By Benzinga Insights

May 4, 6:34 AM

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.

AAOI

1 minute read

Earnings

Aligos Therapeutics Earnings Preview

By Benzinga Insights

May 3, 3:03 PM

Aligos Therapeutics (NASDAQ:ALGS) is set to give its latest quarterly earnings report on Thursday, 2023-05-04. Here’s what investors…

ALGS

10 minute read

Earnings

Earnings Scheduled For March 9, 2023

By Benzinga Insights

March 9, 9:00 AM

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.

ACHR

1 minute read

Aligos Reprioritizes Pipeline With Focus On NASH, COVID Programs, Cuts Another 10% Of Its Workforce

By Vandana Singh

February 9, 12:39 PM

Aligos Therapeutics Inc (NASDAQ:ALGS) announced a portfolio reprioritization, with priorities focused on the rapid advancement of its clinical NASH (ALG-055009)…

ALGS

4 minute read

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

January 17, 2:21 PM

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-211.

ACER